Significance of tyrosine kinase activity on malign transformation of ovarian tumors: A comparison between EGF-R and TGF-α
dc.contributor.author | Zeren T. | |
dc.contributor.author | Inan S. | |
dc.contributor.author | Seda Vatansever H. | |
dc.contributor.author | Ekerbicer N. | |
dc.contributor.author | Sayhan S. | |
dc.date.accessioned | 2024-07-22T08:22:18Z | |
dc.date.available | 2024-07-22T08:22:18Z | |
dc.date.issued | 2008 | |
dc.description.abstract | Epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-α) are members of the polypeptide growth factor family. The epidermal growth factor-receptor (EGF-R) is a receptor tyrosine kinase of the ErbB family. Many types of cancer, including ovarian cancer, display enhanced EGF-R immunoreactivity on their cell surface membranes. Also, an increase in TGF-α synthesis and secretion usually occurs in human carcinoma cell lines. In this study, we compared the immunoreactivities of TGF-α and EGF-R in ovarian tumors and related immunohistochemical findings to the histological type of the tumors. Formalin-fixed, paraffin wax-embedded tissue sections from 40 patients who had serous-mucinous borderline tumor and serous-mucinous adenocarcinoma of the ovary (n=10 each) were stained with hematoxylin-eosin and labeled for binding of primary antibodies against TGF-α and EGF-R using an avidin-biotin-peroxidase method. A semi-quantitative grading system was used to compare immunohistochemical labeling intensities. Increased immunoreactivity of EGF-R and moderate immunoreactivity of TGF-α was detected in adenocarcinomas. There was no significant difference in the immunoreactivity of TGF-α among the histologic types of ovarian tumors. The results of this study support the hypothesis that EGF-R may be a more useful marker than TGF-α in epithelial ovarian tumors. © 2007 Elsevier GmbH. All rights reserved. | |
dc.identifier.DOI-ID | 10.1016/j.acthis.2007.08.007 | |
dc.identifier.issn | 00651281 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19020 | |
dc.language.iso | English | |
dc.publisher | Elsevier GmbH | |
dc.subject | epidermal growth factor receptor | |
dc.subject | protein tyrosine kinase | |
dc.subject | transforming growth factor alpha | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | cell surface | |
dc.subject | clinical article | |
dc.subject | controlled study | |
dc.subject | diagnostic value | |
dc.subject | disease marker | |
dc.subject | female | |
dc.subject | histopathology | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | human tissue | |
dc.subject | immunohistochemistry | |
dc.subject | immunoreactivity | |
dc.subject | malignant transformation | |
dc.subject | ovary adenocarcinoma | |
dc.subject | ovary cancer | |
dc.subject | ovary tumor | |
dc.subject | protein secretion | |
dc.subject | quantitative analysis | |
dc.subject | staining | |
dc.subject | tissue fixation | |
dc.title | Significance of tyrosine kinase activity on malign transformation of ovarian tumors: A comparison between EGF-R and TGF-α | |
dc.type | Article |